How do we eradicate it?
Once a patient has been treated using a standard first-line treatment for H.Pylori and infection eradication fails, the H. pylori remaining can become resistant to a number of the antibiotics used.
The infection then needs to be treated with different antibiotics to reduce the likelihood of creating a “super-resistant” infection.
At the Centre for Digestive Diseases (CDD) we have developed a second-line treatment that has a success rate of greater than 96% (published data), compared to re-treating with the same or similar first-line treatments which have a low success rate.
Our second-line treatments are adjusted to suit each patient based on the number and type of previous treatment.
These are tailored individually based on the patient’s past history, tolerance to medications, lifestyle, diet habits and intensity of H. pylori infection.